48663 Results for: "Gener\\u00E1tory+plynu&pageNo=8"

Supplier: NABERTHERM

Furnace tube rhth120/600/18 p570, 1800c 1 * 1 items

Supplier: NABERTHERM

Furnace high ht 08/18/p570 tmax. 1800c 1 * 1 items

Supplier: Brady

LABEL J40-25-2475 80/ROLL 1 * 1 Roll

Supplier: DELTALAB

BOTTLE OPAQUE N-NECK 1000ML 1 * 80 items

Supplier: Thermo Fisher Scientific

CAP SCREW 18MM WHITE PP 18-400 PE FOAM / PTFE CLOSE TOP 100/PACK 1 * 100 items

Supplier: Thermo Fisher Scientific

Nalgene 30ml beaker 9 x18 rack for for Solaris Shaker 18 x18 , 18 x24 , 18 x30 , and 36 x24 Platforms, 36 places per rack 1 * 1 items

Supplier: Enzo Life Sciences

F4/80 RECOMBINANT MONOCLONAL ANTIBODY (RECOMBINANT CI:A3-1) (RABBIT IGGΚ) 1 * 200 µG

Supplier: Brady

B-417 High-adhesion self-laminating vinyl wraps are designed for tough conditions, including high-humidity environments, small diameter wires and newer wire jacketing materials.

Supplier: BOCHEM

Safety screw with swiveling steel head.

Supplier: Enzo Life Sciences

APROTININ MONOCLONAL ANTIBODY (18) 1 * 1 mg

Supplier: Enzo Life Sciences

COMPLEMENT COMPONENT C4C MONOCLONAL ANTIBODY (99-72-18) 1 * 400 µG

Supplier: Enzo Life Sciences

COMPLEMENT FACTOR D (HUMAN) MONOCLONAL ANTIBODY (18/1B) (BIOTIN CONJUGATE) 1 * 150 µG

Supplier: Enzo Life Sciences

Phospholipase substrate.

Supplier: Enzo Life Sciences

Phospholipase inhibitor

Supplier: Enzo Life Sciences

AACOCF3 is a trifluoromethylketone derivative of arachidonic acid. It is a selective inhibitor of human cytosolic PLA2 and Ca2+-independent PLA2 (iPLA2, IC50=15 µM). It is active in intact platelets and U937 cells (IC50=8 µM). It also inhibits fatty acid amide hydrolase (100% at 7.5 µM).

Supplier: Enzo Life Sciences

Propranolol blocks PLD derived DAG formation by inhibiting phosphatidate phosphohydrolase (IC50=70 µM). It is a useful tool to discriminate between PLC or PLD mediated DAG production. It is also a β-adrenergic receptor blocking agent.

Supplier: Enzo Life Sciences

IM-12 ≥98% (by HPLC)

Supplier: Enzo Life Sciences

HDAC inhibitor developed at Enzo Life Sciences. Inhibits HDAC activity in HeLa nuclear extracts (IC50=5-10µM).

Supplier: Enzo Life Sciences

Chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Reversibly blocks p53-dependent transcriptional activation and apoptosis. Protects against neuronal death in models of stroke and neurodegenerative disorders. Suppresses self-renewal of embryonic stem cells.

Supplier: Enzo Life Sciences

Primary metabolite of arachidonic acid via the 12-lipoxygenase pathway. Inhibits thromboxane synthase. Inhibits platelet aggregation via activation of guanylate cyclase (100% at 5µM). Stimulates leukotriene biosynthesis. Potent and selective inhibitor of Ca2+-calmodulin-dependent protein kinase II (IC50=0.7µM). Endogenous TRPV1 agonist (Ki=0.35µM).

Supplier: Enzo Life Sciences

Biosynthesis via 15-OH prostaglandin dehydrogenase from lung and liver microsomes and by a nonenzymatic process.

Supplier: Enzo Life Sciences

LPA receptor ligand

Supplier: Enzo Life Sciences

Prostanoid receptor ligand.

Supplier: Enzo Life Sciences

Endogenous lipid which significantly reduced food intake in a dose-dependent fashion when administered to rats and mice (100 mg/kg, i.p.), without causing taste aversion. Has been found to enter the brain (concentrating in the hypothalamus) when administered systemically and also reduced food intake when infused intracerebroventricularly (nanomolar concentrations). This suggests that mediation of effects is via the CNS. Chronic infusion resulted in a reduction of both food intake and body weight.

Supplier: Enzo Life Sciences

PP2A inhibitor

Supplier: Enzo Life Sciences

Biosynthesis via hydrolysis of prostacyclin. A reliable parameter for measurement of prostacyclin. Ultra-pure.

Supplier: Enzo Life Sciences

Biosynthesis via liver and renal cytochrome P-450. Induces glucagon release from pancreatic islets. Vasodilator in intestinal microcirculation. Inhibits Na+K+-ATPase. Urinary excretion in humans is increased during pregnancy-induced hypertension.

Supplier: Enzo Life Sciences

Lipoxygenase inhibitor

Supplier: Enzo Life Sciences

A potent and specific substrate analog PLA2 inhibitor (IC50=6.2 µM-porcine pancreatic PLA2). It inhibits human recombinant sPLA2 (IC50=13.7 µM) selectively over cPLA2. At 1 µM it completely blocked the myogenic response in perfused dog renal arcuate arteries.

Supplier: Enzo Life Sciences

Cyclooxygenase inhibitor. Selectively inhibits PGH synthase-2 (IC50=1 µM) with no inhibition of PGH synthase-1 at concentrations up to 100 µM. Protects neuronal cultures from LPS-induced neurotoxicity.